ctrl K

Watchlist Price Alert

Sorrento Therapeutics Inc... (SRNE)

OTC: SRNE · Real-Time Price · USD

0.00

-0.00 (-100.00%)

At close: Apr 04, 2025, 3:54 PM

Sorrento Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	62.84M	52.9M	39.99M	31.43M	21.19M	151.86M	8.15M
Cost of Revenue	33.45M	13.03M	9.94M	12.24M	10.07M	11.03M	3.7M
Gross Profit	29.39M	39.87M	30.05M	19.2M	11.12M	140.83M	4.46M
Operating Income	-504.31M	-368.05M	-201.53M	-195.18M	-129.48M	52.34M	-59.9M
Interest Income	n/a	n/a	24K	1.09M	921K	241K	272K
Pretax Income	-561.75M	-462.53M	-310.58M	-359.58M	-213.78M	15.31M	-64.83M
Net Income	-572.84M	-429.01M	-308.57M	-359.1M	-203.54M	9.06M	-60.92M
Selling & General & Admin	182.34M	196.86M	116.18M	103.56M	63.64M	32.96M	22.18M
Research & Development	221.23M	206.92M	111.34M	106.88M	76.96M	55.53M	42.17M
Other Expenses	130.14M	4.14M	4.05M	3.94M	3.01M	2.61M	845K
Operating Expenses	533.7M	407.92M	231.57M	214.38M	140.6M	88.49M	64.35M
Interest Expense	8.57M	10.22M	20.18M	36.14M	57.63M	4.98M	1.61M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	-5.37M	-2.04M
Cost & Expenses	567.15M	420.95M	241.51M	226.61M	150.67M	99.52M	68.05M
Income Tax Expense	-2.42M	-33.52M	-2.01M	-473K	-6.27M	-36.04M	-896K
Shares Outstanding (Basic)	419.31M	294.77M	229.82M	140.51M	106.15M	69.74M	50.36M
Shares Outstanding (Diluted)	419.31M	294.77M	229.82M	140.51M	106.15M	70.38M	50.36M
EPS (Basic)	-1.37	-1.46	-1.34	-2.56	-1.92	0.13	-1.21
EPS (Diluted)	-1.37	-1.46	-1.34	-2.56	-1.92	0.13	-1.21
EBITDA	-539.93M	-435.99M	-275.69M	-308.39M	-147.1M	27.38M	-60.34M
EBIT	-553.17M	-452.3M	-290.42M	-324.53M	-156.15M	20.3M	-63.66M
Depreciation & Amortization	13.24M	16.32M	14.71M	15.04M	9.05M	7.08M	2.88M